Function: Precision Medicine Company Function Oncology Raises $28 Million

Function Oncology - a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to transform the future of targeted cancer treatment - announced its launch with $28 million in Series A financing. The funding was led by a16z and Section 32, with participation from Casdin Capital and Alexandria Venture Investments. The post Precision Medicine Company Function Oncology Raises $28 Million appeared first on Pulse 2.0.